✦ LIBER ✦

Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study

✍ Scribed by Cortes, Jorge; Feldman, Eric; Yee, Karen; Rizzieri, David; Advani, Anjali S; Charman, Anthony; Spruyt, Richard; Toal, Martin; Kantarjian, Hagop

Book ID: 123599667
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 261 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(13)70037-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

509 The OPAL Study: A Phase II Study to

509 The OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia

✍ Jorge Cortes; Eric Feldman; Karen Yee; Martin Toal; Alison Richardson; Anthony C 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 130 KB

A phase 2 study of belinostat (PXD101) i

A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study

✍ Kirschbaum, Mark H.; Foon, Kenneth A.; Frankel, Paul; Ruel, Christopher; Pulone, 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 117 KB

OR7-8: A phase II randomised, open-label

OR7-8: A phase II randomised, open-label, parallelgroup study of the safety, tolerability, pharmacokinetics and efficacy of two subcutaneous dosing regimens of ATL1103 in adult patients with acromegaly

✍ Trainer, P.J.; Newell-Price, J.; Ayuk, J.; Aylwin, S.; Drake, W.M.; Rees, A.; Ch 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 449 KB

A multicenter, open-label, phase 2 study

A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial

✍ Jian Hou, Xin Du, Jie Jin, Zhen Cai, Fangping Chen… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 427 KB

Results of a phase 2 study of valproic a

Results of a phase 2 study of valproic acid alone or in combination with all-transretinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

✍ Andrea Kuendgen; Sabine Knipp; Frank Fox; Corinna Strupp; Barbara Hildebrandt; C 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 97 KB

An open-label, single-arm, phase 2 study

An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib

✍ Ravi Vij; David S. Siegel; Sundar Jagannath; Andrzej J. Jakubowiak; Alexander Ke 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB